Knockdown of KCNQ1OT1 could alter the tumor microenvironment, inhibit T-cell apoptosis and promote HCC cell apoptosis, thus inhibiting HCC cell resistance to sorafenib and cell metastasis (51). Here, KCNQ1OT1 is linked to hepatocellular carcinoma.